← SynDRA
GLIPIZIDE
SynDRA canonical compound SYN0003512 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ABCC8 |
|---|
| Mechanism of action | Sulfonylurea |
|---|
| Indication | diabetes mellitus | hyperglycemia |
|---|
| Disease area | endocrinology |
|---|
All known targets
- ABCC8
- KCNJ11
- KCNJ10
- PPARG
Mechanisms of action (all sources)
- Sulfonylurea
- KCNJ11 BLOCKER
- Sulfonylurea receptor 1, Kir6.2 blocker
- ABCC8 BLOCKER
- KCNJ10 BLOCKER
Drug classes
- Hypoglycemic Agents
- Sulfonylurea
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- glypidizine
- glidiazinamide
- K-4024
- K4024
- dipazide
- glibenese
- glipizid
- glucotrol
- glucozide
- glupizide
- glydiazinamide
- melizide
- napizide
- sucrazide
- Glipizida
- Glipizide slow release
- CP-28,720
- CP-28720
- NSC-759120
- Glibenese
- Glipizide component of metaglip
- Glucotrol
- Glucotrol xl
- Minodiab 2.5
- Minodiab 5
- Aldiab
- Digrin
- Dipazide
- Glibetin
- Glican
- Glide
- Glidiab
- Glidiazinamide
- Glipid
- Glipizidum
- Glucolip
- Glucozide
- Glupitel
Reported adverse events
- Lactic acid
- Lactic acidosis
- Dizziness
- Leukopenia
- Porphyria
- Headache
- Hypertension
- Nausea
- Abdominal pain
- Musculoskeletal pain
Look up GLIPIZIDE in the interactive SynDRA portal →